查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1705972

全球霍乱疫苗市场按产品类型、疫苗类型、患者类型、分销管道和地区划分

Global Cholera Vaccines Market, By Product Type, By Vaccine Type, By Patient Type, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球霍乱疫苗市场规模估计为 8,270 万美元，预计到 2032 年将达到 1.851 亿美元，2025 年至 2032 年的年复合成长率(CAGR)为 12.20%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 8270万美元
效能数据 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 12.20% 2032年价值预测 1.851亿美元
数字。 2025年全球市场占有率（按地区）
全球霍乱疫苗市场-IMG1

霍乱是一种细菌性疾病，通常透过受污染的水传播。它会导致严重的腹泻和脱水，如果不及时治疗，可能会在几个小时内致命。这种疾病在水处理不良、卫生条件差和不卫生的地区最为常见，包括非洲、东南亚和海地。世界卫生组织（WHO）和联合国儿童基金会（UNICEF）警告称，霍乱正在以毁灭性的方式死灰復燃，尤其针对脆弱群体。在贫穷、战争或天灾迫使人们生活在拥挤且缺乏足够卫生设施的地方，霍乱爆发的风险最大。霍乱是一种贫困疾病，影响那些无法获得安全饮用水和基本卫生设施的人。霍乱不会在人与人之间直接传播，因此与感染者的偶然接触并不是罹患此疾病的重要风险因子。多管齐下的预防方法是消除霍乱和减少死亡的关键。这包括在高风险地区获得安全饮用水、适当的卫生设施和卫生习惯以及疫苗接种。

市场动态：

推动全球霍乱疫苗市场成长的关键因素包括全球霍乱疾病负担的增加、对预防霍乱疫情的日益关注以及市场上出现可提供更长保护时间的新型口服疫苗。然而，低收入地区疫苗接种可近性不足、部分地区疫苗接种意识低下等因素持续在一定程度上限制市场潜力。乐观的一面是，加大对可对多种血清型提供交叉保护的疫苗的研究投入，正在开闢新的途径。製造商和国际组织之间为提高流行地区的供应而伙伴关係也为未来几年带来了诱人的机会。

本研究的主要特点

  • 本报告对全球霍乱疫苗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率(CAGR)。
  • 它还强调了不同领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 该报告涵盖了全球霍乱疫苗市场的主要企业概况，基于公司亮点、产品系列、主要产品亮点、财务表现和策略等参数。
  • 从本报告中获得的见解将使负责人和企业经营团队能够就未来的产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。
  • 全球霍乱疫苗市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 透过用于分析全球霍乱疫苗市场的各种策略矩阵，相关人员可以更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 加强疫苗宣传活动
    • 霍乱疫苗供不应求
    • 增加教育和培训项目
  • 主要亮点
  • 监管情景
  • 市场趋势
  • 管道分析
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 流行病学
  • 治疗流程（病人历程）
  • 治疗方案分析
  • 主要市场参与者的新投资
  • 定价分析
  • 疾病意识计划
  • 分析治疗的安全性和有效性
  • 合併、收购和合作

4. 全球霍乱疫苗市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球霍乱疫苗市场（依产品类型）

  • 瓦什科拉
  • 杜科拉尔
  • ShanChol
  • Euvichol-Plus/ Euvichol
  • 其他（后期疫苗等）

6. 2020-2032 年全球霍乱疫苗市场（依疫苗类型）

  • 灭活全细胞和重组霍乱毒素B疫苗
  • 灭活全细胞疫苗
  • 口服霍乱减毒活疫苗

7. 2020-2032 年全球霍乱疫苗市场（依病患类型）

  • 孩子们
  • 成人

8. 2020-2032 年全球霍乱疫苗市场（依通路划分）

  • 公共
  • 私人的

9. 2020-2032 年全球霍乱疫苗市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十章 竞争格局

  • 公司简介
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd（Hillhouse Capital）
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.

第 11 章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6646

Global Cholera Vaccines Market is estimated to be valued at USD 82.7 Mn in 2025 and is expected to reach USD 185.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.20% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 82.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.20% 2032 Value Projection: USD 185.1 Mn
Figure. Global Cholera Vaccines Market Share (%), By Region 2025
Global Cholera Vaccines Market - IMG1

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.

Market Dynamics:

Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.

Key features of the study:

  • This report provides in-depth analysis of the global cholera vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market

Detailed Segmentation:

  • Global Cholera Vaccines Market, By Product Type
    • Vaxchora
    • Dukoral
    • ShanChol
    • Euvichol-Plus/Euvichol
    • Others (Late Phase Vaccines, etc.)
  • Global Cholera Vaccines Market, By Vaccine Type
    • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Killed Whole-cell Only Vaccines
    • Live Attenuated Oral Cholera Vaccine
  • Global Cholera Vaccines Market, By Patient Type
    • Pediatric
    • Adults
  • Global Cholera Vaccines Market, By Distribution Channel
    • Public
    • Private
  • Global Cholera Vaccines Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing Vaccination Campaigns
    • Supply Shortage of Cholera Vaccine
    • Increasing Educational Training Programmes
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Pipeline Analysis
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • Treatment Algorithm (Patient Journey)
  • Treatment Option Analysis
  • New Investments by Major Market Players
  • Pricing Analysis
  • Disease Awareness Programs
  • Treatment Safety and Efficacy Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Cholera Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cholera Vaccines Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Vaxchora
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Dukoral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • ShanChol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Euvichol-Plus/Euvichol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Late Phase Vaccines, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Cholera Vaccines Market, By Vaccine Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Killed Whole-cell Only Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Live Attenuated Oral Cholera Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Cholera Vaccines Market, By Patient Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Cholera Vaccines Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 201s9-2032,(US$ Mn)

9. Global Cholera Vaccines Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profile
    • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Biovac.co.za.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • EMERGENT
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Celldex Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Valneva SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hilleman Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • PaxVax, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Astellas Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • EUBIOLOGICS CO., LTD.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us